Analysis Field Trip white paper makes strong health and business case for ketamine therapy With solid efficacy and low cost, the popular club drug could help curb the personal toll and multi-billion dollar cost of North America's battle... Natalia Buendia CalvilloFebruary 9, 2021
The weed wire Aleafia Health clinics to offer ketamine-based antidepressant Spravato can be prescribed for treatment-resistant depressive disorder Michelle GamageJuly 24, 2020
The weed wire Champignon Brands grows research cap with AltMed acquisition The psychedelic medicine company has surged since going public last month and is quickly expanding its research footprint Jared GnamApril 13, 2020